Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family Study
- PMID: 26209557
- PMCID: PMC4731407
- DOI: 10.1093/toxsci/kfv164
Linkage Analysis of Urine Arsenic Species Patterns in the Strong Heart Family Study
Abstract
Arsenic toxicokinetics are important for disease risks in exposed populations, but genetic determinants are not fully understood. We examined urine arsenic species patterns measured by HPLC-ICPMS among 2189 Strong Heart Study participants 18 years of age and older with data on ~400 genome-wide microsatellite markers spaced ~10 cM and arsenic speciation (683 participants from Arizona, 684 from Oklahoma, and 822 from North and South Dakota). We logit-transformed % arsenic species (% inorganic arsenic, %MMA, and %DMA) and also conducted principal component analyses of the logit % arsenic species. We used inverse-normalized residuals from multivariable-adjusted polygenic heritability analysis for multipoint variance components linkage analysis. We also examined the contribution of polymorphisms in the arsenic metabolism gene AS3MT via conditional linkage analysis. We localized a quantitative trait locus (QTL) on chromosome 10 (LOD 4.12 for %MMA, 4.65 for %DMA, and 4.84 for the first principal component of logit % arsenic species). This peak was partially but not fully explained by measured AS3MT variants. We also localized a QTL for the second principal component of logit % arsenic species on chromosome 5 (LOD 4.21) that was not evident from considering % arsenic species individually. Some other loci were suggestive or significant for 1 geographical area but not overall across all areas, indicating possible locus heterogeneity. This genome-wide linkage scan suggests genetic determinants of arsenic toxicokinetics to be identified by future fine-mapping, and illustrates the utility of principal component analysis as a novel approach that considers % arsenic species jointly.
Keywords: Strong Heart Family Study; arsenic metabolism; arsenic species; linkage analysis; toxicogenetics; toxicokinetics.
© The Author 2015. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures





Similar articles
-
Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10.J Appl Toxicol. 2010 Apr;30(3):260-70. doi: 10.1002/jat.1492. J Appl Toxicol. 2010. PMID: 20014157 Free PMC article.
-
Metabolomic profiles of arsenic (+3 oxidation state) methyltransferase knockout mice: effect of sex and arsenic exposure.Arch Toxicol. 2017 Jan;91(1):189-202. doi: 10.1007/s00204-016-1676-0. Epub 2016 Feb 16. Arch Toxicol. 2017. PMID: 26883664 Free PMC article.
-
Heritability and preliminary genome-wide linkage analysis of arsenic metabolites in urine.Environ Health Perspect. 2013 Mar;121(3):345-51. doi: 10.1289/ehp.1205305. Epub 2013 Jan 15. Environ Health Perspect. 2013. PMID: 23322787 Free PMC article.
-
[Relationship between Arsenic (+3 Oxidation State) Methyltransferase Genetic Polymorphisms and Methylation Capacity of Inorganic Arsenic].Nihon Eiseigaku Zasshi. 2015;70(3):186-96. doi: 10.1265/jjh.70.186. Nihon Eiseigaku Zasshi. 2015. PMID: 26411936 Review. Japanese.
-
Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms.Int J Mol Sci. 2011;12(4):2351-82. doi: 10.3390/ijms12042351. Epub 2011 Apr 4. Int J Mol Sci. 2011. PMID: 21731446 Free PMC article. Review.
Cited by
-
A missense variant in FTCD is associated with arsenic metabolism and toxicity phenotypes in Bangladesh.PLoS Genet. 2019 Mar 20;15(3):e1007984. doi: 10.1371/journal.pgen.1007984. eCollection 2019 Mar. PLoS Genet. 2019. PMID: 30893314 Free PMC article.
-
Association Between Variants in Arsenic (+3 Oxidation State) Methyltranserase (AS3MT) and Urinary Metabolites of Inorganic Arsenic: Role of Exposure Level.Toxicol Sci. 2016 Sep;153(1):112-23. doi: 10.1093/toxsci/kfw112. Epub 2016 Jun 30. Toxicol Sci. 2016. PMID: 27370415 Free PMC article.
-
The Human Gut Microbiome's Influence on Arsenic Toxicity.Curr Pharmacol Rep. 2019 Dec;5(6):491-504. doi: 10.1007/s40495-019-00206-4. Epub 2019 Nov 25. Curr Pharmacol Rep. 2019. PMID: 31929964 Free PMC article.
-
Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults.Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012649. doi: 10.1002/14651858.CD012649.pub2. Cochrane Database Syst Rev. 2021. PMID: 34661903 Free PMC article.
-
Association of Cardiometabolic Genes with Arsenic Metabolism Biomarkers in American Indian Communities: The Strong Heart Family Study (SHFS).Environ Health Perspect. 2017 Jan;125(1):15-22. doi: 10.1289/EHP251. Epub 2016 Jun 28. Environ Health Perspect. 2017. PMID: 27352405 Free PMC article.
References
-
- Agusa T., Kunito T., Kubota R., Inoue S., Fujihara J., Minh T. B., Ha N. N., Tu N. P., Trang P. T., Chamnan C., et al. (2010). Exposure, metabolism, and health effects of arsenic in residents from arsenic-contaminated groundwater areas of Vietnam and Cambodia: a review. Rev. Environ. Health 25, 193–220. - PubMed
-
- Ahsan H., Chen Y., Kibriya M. G., Slavkovich V., Parvez F., Jasmine F., Gamble M. V., Graziano J. H. (2007). Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomark. Prev. 16, 1270–1278. - PubMed
-
- Alexeeff G. V., Broadwin R., Liaw J., Dawson S. V. (2002). Characterization of the LOAEL-to-NOAEL uncertainty factor for mild adverse effects from acute inhalation exposures. Regul. Toxicol. Pharmacol. 36, 96–105. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HL65521/HL/NHLBI NIH HHS/United States
- T32ES013678-07/ES/NIEHS NIH HHS/United States
- U01 HL041652/HL/NHLBI NIH HHS/United States
- R01ES021367/ES/NIEHS NIH HHS/United States
- T32 ES013678/ES/NIEHS NIH HHS/United States
- R01 HL109284/HL/NHLBI NIH HHS/United States
- U01 HL065521/HL/NHLBI NIH HHS/United States
- P30 ES019776/ES/NIEHS NIH HHS/United States
- R01 HL109301/HL/NHLBI NIH HHS/United States
- P30 ES007048/ES/NIEHS NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- U01 HL041642/HL/NHLBI NIH HHS/United States
- HL41652/HL/NHLBI NIH HHS/United States
- U01 HL041654/HL/NHLBI NIH HHS/United States
- C06 RR017515/RR/NCRR NIH HHS/United States
- R01 HL090863/HL/NHLBI NIH HHS/United States
- C06 RR013556/RR/NCRR NIH HHS/United States
- HL41642/HL/NHLBI NIH HHS/United States
- HL41654/HL/NHLBI NIH HHS/United States
- R01 ES021367/ES/NIEHS NIH HHS/United States
- R01HL090863/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical